XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells

Apoptosis

Volumn 16, Issue 5, 2011, Pages 502-510

  Liu, Yan ^a,e   Liu, Aiguo ^a,d   Xu, Zhenghu ^b   Yu, Wenying ^c   Wang, Hong ^b   Li, Chenglong ^c   Lin, Jiayuh ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MIAMI UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Apoptosis; Hepatocellular carcinoma; Interleukin 6; STAT3

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; INTERLEUKIN 6; PROTEIN INHIBITOR; SD 1029; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; XZH 5;

APOPTOSIS; ARTICLE; CARCINOMA CELL; COLONY FORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC S-OXIDES; HISTIDINE; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; PHENYLUREA COMPOUNDS; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; XANTHENES;

EID: 79955839265     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0578-0     Document Type: Article

References (49)

1. RT Greenlee MB Hill-Harmon T Murray M Thun 2001 Cancer statistics CA Cancer J Clin 51 15 36 11577478 10.3322/canjclin.51.1.15 1:STN:280: DC%2BD3MrjtFGisg%3D%3D
2. C Berasain J Castillo MJ Perugorria MU Latasa J Prieto MA Avila 2009 Inflammation and liver cancer: new molecular links Ann N Y Acad Sci 1155 206 221 19250206 10.1111/j.1749-6632.2009.03704.x 1:CAS:528:DC%2BD1MXktFKltrk%3D
3. M Sherman 2005 Hepatocellular carcinoma: epidemiology, risk factors, and screening Semin Liver Dis 25 143 154 15918143 10.1055/s-2005-871194 (Pubitemid 40781067)
4. JF Wilson 2005 Liver cancer on the rise Ann Intern Med 142 1029 1032 15968025 (Pubitemid 40840324)
5. FX Bosch J Ribes R Cleries M Diaz 2005 Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 191 211 15831268 10.1016/j.cld.2004.12.009 v
6. JF Bromberg MH Wrzeszczynska G Devgan, et al. 1999 Stat3 as an oncogene Cell 98 295 303 10458605 10.1016/S0092-8674(00)81959-5 1:CAS:528: DyaK1MXlt1Cgt7s%3D (Pubitemid 29380565)
7. R Buettner LB Mora R Jove 2002 Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention Clin Cancer Res 8 945 954 11948098 1:CAS:528:DC%2BD38XjsF2lsb4%3D (Pubitemid 35177340)
8. H Yu M Kortylewski D Pardoll 2007 Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat Rev Immunol 7 41 51 17186030 10.1038/nri1995 1:CAS:528:DC%2BD28XhtlCht7fE (Pubitemid 46020826)
9. H Yu D Pardoll R Jove 2009 STATs in cancer inflammation and immunity: a leading role for STAT3 Nat Rev Cancer 9 798 809 19851315 10.1038/nrc2734 1:CAS:528:DC%2BD1MXhtlSjur%2FP
10. G Niu KL Wright M Huang, et al. 2002 Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2000 2008 11960372 10.1038/sj.onc.1205260 1:CAS:528:DC%2BD38XivVelur4%3D (Pubitemid 34270888)
11. PJ Real A Sierra A De Juan JC Segovia JM Lopez-Vega JL Fernandez-Luna 2002 Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 21 7611 7618 12400004 10.1038/sj.onc.1206004 1:CAS:528:DC%2BD38XotFWrtb8%3D (Pubitemid 35398808)
12. LH Wei ML Kuo CA Chen, et al. 2003 Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway Oncogene 22 1517 1527 12629515 10.1038/sj.onc.1206226 1:CAS:528:DC%2BD3sXhvFShtbY%3D (Pubitemid 36390601)
13. T Wang G Niu M Kortylewski, et al. 2004 Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nat Med 10 48 54 14702634 10.1038/nm976 (Pubitemid 38524698)
14. J Turkson S Zhang LB Mora A Burns S Sebti R Jove 2005 A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells J Biol Chem 280 32979 32988 16046414 10.1074/jbc.M502694200 1:CAS:528:DC%2BD2MXhtVWiurrL (Pubitemid 41368347)
15. S Nam R Buettner J Turkson, et al. 2005 Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells Proc Natl Acad Sci U S A 102 5998 6003 15837920 10.1073/pnas.0409467102 1:CAS:528: DC%2BD2MXkt1Cmu78%3D (Pubitemid 40594244)
16. SO Rahaman PC Harbor O Chernova GH Barnett MA Vogelbaum SJ Haque 2002 Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells Oncogene 21 8404 8413 12466961 10.1038/sj.onc.1206047 1:CAS:528:DC%2BD38Xpt1WitLo%3D (Pubitemid 36054883)
17. X Li H Wang X Lu B Di 2010 STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells Oncol Rep 23 345 353 20043094 1:CAS:528:DC%2BC3cXitVyqsrk%3D
18. Y Liu PK Li C Li J Lin 2010 Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells J Biol Chem 285 27429 27439 20562100 10.1074/jbc.M110.142752 1:CAS:528:DC%2BC3cXhtVKhs7nL
19. L Lin R Amin GI Gallicano, et al. 2009 The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling Oncogene 28 961 972 19137011 10.1038/onc.2008.448 1:CAS:528:DC%2BD1MXitFKltLc%3D
20. Zhang B, Zhong DW, Wang QW, et al. (2010) Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26:368-370, 373
21. A Hosui A Kimura D Yamaji BM Zhu R Na L Hennighausen 2009 Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation J Exp Med 206 819 831 19332876 10.1084/jem.20080003 1:CAS:528:DC%2BD1MXkvVSiu74%3D
22. NK Saxena D Sharma X Ding, et al. 2007 Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells Cancer Res 67 2497 2507 17363567 10.1158/0008-5472.CAN-06-3075 1:CAS:528:DC%2BD2sXivV2gu7s%3D (Pubitemid 46548934)
23. WC Li SL Ye RX Sun, et al. 2006 Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3 Clin Cancer Res 12 7140 7148 17145839 10.1158/1078-0432.CCR-06-0484 1:CAS:528:DC%2BD28Xht1Kns7bP (Pubitemid 44974515)
24. J Li YF Piao Z Jiang L Chen HB Sun 2009 Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice World J Gastroenterol 15 2602 2608 19496189 10.3748/wjg.15.2602 1:CAS:528: DC%2BD1MXpsF2rtLo%3D
25. SR Choudhari MA Khan G Harris, et al. 2007 Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod Mol Cancer Ther 6 112 121 17237271 10.1158/1535-7163.MCT-06-0561 1:CAS:528:DC%2BD2sXmsVantA%3D%3D (Pubitemid 46206673)
26. L Lin S Deangelis E Foust, et al. 2010 A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells Mol Cancer 9 217 20712901 10.1186/1476-4598-9-217 1:CAS:528:DC%2BC3cXhtlKrt7nM
27. J Bollrath TJ Phesse VA von Burstin, et al. 2009 gp130-mediated STAT3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis Cancer Cell 15 91 102 19185844 10.1016/j.ccr.2009.01.002 1:CAS:528:DC%2BD1MXltFSmtLo%3D
28. M Berishaj SP Gao S Ahmed, et al. 2007 STAT3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer Breast Cancer Res 9 R32 17531096 10.1186/bcr1680 (Pubitemid 350215175)
29. M Soresi L Giannitrapani F D'Antona, et al. 2006 Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma World J Gastroenterol 12 2563 2568 16688802 1:CAS:528:DC%2BD28XlvVSrurk%3D
30. EJ Park JH Lee GY Yu, et al. 2010 Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 197 208 20141834 10.1016/j.cell.2009.12.052 1:CAS:528:DC%2BC3cXkvVWitLw%3D
31. Z Duan JE Bradner E Greenberg, et al. 2006 SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation Clin Cancer Res 12 6844 6852 17121906 10.1158/1078-0432.CCR-06-1330 1:CAS:528: DC%2BD28Xht1elsL3O (Pubitemid 44876855)
32. JS McMurray 2006 A new small molecule STAT3 inhibitor Chem Biol 13 1123 1124 17113993 10.1016/j.chembiol.2006.11.001 1:CAS:528:DC%2BD28Xht1Cis7bM (Pubitemid 44750737)
33. J Schust B Sperl A Hollis TU Mayer T Berg 2006 Stattic: a small molecule inhibitor of STAT3 activation and dimerization Chem Biol 13 1235 1242 17114005 10.1016/j.chembiol.2006.09.018 1:CAS:528:DC%2BD28Xht1Cis7fP (Pubitemid 44750735)
34. D Puthier R Bataille M Amiot 1999 IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway Eur J Immunol 29 3945 3950 10602002 10.1002/(SICI)1521-4141(199912)29:12<3945::AID- IMMU3945>3.0.CO;2-O 1:CAS:528:DyaK1MXotVehs74%3D
35. T Fukada M Hibi Y Yamanaka, et al. 1996 Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis Immunity 5 449 460 8934572 10.1016/S1074-7613(00)80501-4 1:CAS:528:DyaK28Xntleju70%3D (Pubitemid 26423473)
36. DJ Dauer B Ferraro L Song, et al. 2005 STAT3 regulates genes common to both wound healing and cancer Oncogene 24 3397 3408 15735721 10.1038/sj.onc.1208469 1:CAS:528:DC%2BD2MXktVKnurs%3D (Pubitemid 40756241)
37. R Garcia TL Bowman G Niu, et al. 2001 Constitutive activation of STAT3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 20 2499 2513 11420660 10.1038/sj.onc.1204349 1:CAS:528:DC%2BD3MXjvFGmt7k%3D (Pubitemid 32531347)
38. WM Burke X Jin HJ Lin, et al. 2001 Inhibition of constitutively active STAT3 suppresses growth of human ovarian and breast cancer cells Oncogene 20 7925 7934 11753675 10.1038/sj.onc.1204990 1:CAS:528:DC%2BD3MXptlKku7Y%3D (Pubitemid 34002969)
39. CL Chen FC Hsieh JC Lieblein, et al. 2007 STAT3 activation in human endometrial and cervical cancers Br J Cancer 96 591 599 17311011 10.1038/sj.bjc.6603597 1:CAS:528:DC%2BD2sXhvV2jtrc%3D
40. HH Yeh WW Lai HH Chen HS Liu WC Su 2006 Autocrine IL-6-induced STAT3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 25 4300 4309 16518408 10.1038/sj.onc.1209464 1:CAS:528:DC%2BD28XntVWks7o%3D (Pubitemid 44100500)
41. DS Shin HN Kim KD Shin, et al. 2009 Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells Cancer Res 69 193 202 19118003 10.1158/0008-5472.CAN-08-2575 1:CAS:528:DC%2BD1MXmvFCm
42. DA Frank 2007 STAT3 as a central mediator of neoplastic cellular transformation Cancer Lett 251 199 210 17129668 10.1016/j.canlet.2006.10.017 1:CAS:528:DC%2BD2sXkvFGrsLk%3D (Pubitemid 46680370)
43. BB Aggarwal AB Kunnumakkara KB Harikumar, et al. 2009 Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171 59 76 19723038 10.1111/j.1749-6632.2009. 04911.x 1:CAS:528:DC%2BD1MXht1Sntb3J
44. M Masuda M Suzui R Yasumatu, et al. 2002 Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma Cancer Res 62 3351 3355 12067972 1:CAS:528: DC%2BD38XkslWqsL8%3D (Pubitemid 34651376)
45. N Kiuchi K Nakajima M Ichiba, et al. 1999 STAT3 is required for the gp130-mediated full activation of the c-myc gene J Exp Med 189 63 73 9874564 10.1084/jem.189.1.63 1:CAS:528:DyaK1MXjs1Ogtg%3D%3D (Pubitemid 29047027)
46. T Shirogane T Fukada JM Muller DT Shima M Hibi T Hirano 1999 Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis Immunity 11 709 719 10626893 10.1016/S1074-7613(00)80145-4 1:CAS:528:DC%2BD3cXkt1Siug%3D%3D (Pubitemid 30030710)
47. R Catlett-Falcone TH Landowski MM Oshiro, et al. 1999 Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells Immunity 10 105 115 10023775 10.1016/S1074-7613(00)80011-4 1:CAS:528:DyaK1MXhtFarsbo%3D (Pubitemid 29077388)
48. K Mahboubi F Li J Plescia, et al. 2001 Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway Lab Invest 81 327 334 11310826 1:CAS:528:DC%2BD3MXivVKqsLw%3D (Pubitemid 32245065)
49. S Grivennikov E Karin J Terzic, et al. 2009 IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 103 113 19185845 10.1016/j.ccr.2009.01. 001 1:CAS:528:DC%2BD1MXltFSmtLs%3D